CSIR-CDRI has a strong commitment to training the next generation of scientists. This includes
students pursuing Ph.D degrees, trainees in skill development programs and projects associates
recruited for research support. Our alumni occupy leading roles in academia and industry
across the world, a testament to the high quality learning experience and mentorship received
at CDRI.
CSIR-CDRI works closely with partners in academia, industry and non-profit organizations. We
have established collaborations with multiple international agencies such as the Bill & Melinda
Gates Foundation (BMGF) , Medicines for Malaria Venture (MMV),
Drugs for Neglected Diseases initiative (DNDi), and BFI Biome Network (BFI). Our industry partners include Cipla, Dr. Reddy’s
Laboratories, Zydus Life Sciences, Themis Medicare, Escee Biotech and many others. Our
clinical and academic collaborators include King George's Medical University, Sanjay Gandhi
Post Graduate Institute of Medical Sciences, All India Institute of Medical Sciences, Manipal
Academy of Higher Education, IITs, IISERs, NIPERs, DRDO, DBT/DST institutions and many
others. We are supported by generous funding from diverse sources such as CSIR, ICMR, DBT,
DST, BIRAC, IGNITE, BMGF, BFI.
Our collaboration models leverage complementary capabilities and promote innovative
research and product development. We also offer R&D services to academia and industry. In
particular, we support MSME in the pharmaceutical and biotechnology sector through the
Common Research and Technology Development Hub (CRTDH), funded by the Department of
Science and Technology, Government of India.
The CSIR-CDRI campus has state-of-the art laboratories equipped with advanced technologies
and instruments. The campus houses sophisticated analytical and imaging facilities, a
molecular and structural biology laboratory, a national facility for laboratory animals and a
large repository of compounds. Of note, CSIR-CDRI has a NGCMA certified GLP facility for
Regulatory toxicity and Safety Pharmacology studies for Pharmaceuticals.
With a multicultural community focused on high quality research, CSIR-CDRI’s commitment to
addressing India’s healthcare needs remains resolute. It is our hope that the impact of our work
continually expands and contributes to positive health outcomes.